CHICAGO (January 31, 2020): Virtual antibody crossmatching is a safe and efficient way of selecting kidney transplant recipients. Two years after implementing the process, the Medical University of ...
For patients who undergo desensitization treatment to reduce or neutralize circulating donor-specific anti-HLA antibodies prior to transplantation, survival is lower than for unsensitized patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results